Childhood Vaccinations

What are all the childhood vaccinations, how it works and why it is mandatory.

Childhood immunization programs use small amounts of biological agents (called, antigens) which is reduced in size, force and intensity, in order to stimulate the immune system. This helps the immune system to protect against infectious disease causing bacteria such as for example, diphtheria, pertussis, and measles (which in medical terms are called pathogens). By introducing these antigens, the body develops immunological memory, allowing for a rapid response if the pathogen is encountered later on.

Booster Doses

Often, the administration of booster dosses (more doses of the vaccine) is essential to maintain the efficacy of the immune response over time, to ‘boost’ immunological memory, because the immune response may wane across the developmental stages of childhood.

Why then mamdatory?

The reason why most vaccinations are mandatory is because the more people are immunised, it can result in population immunity, which effectively curtails disease incidence (number of new cases) and protects vulnerable individuals who cannot be vaccinated. This public health strategy is further reinforced by rigorous national and international immunization schedules that dictate the precise timing of vaccine administration to ensure maximum safety and community-wide disease prevention. This comprehensive approach ensures that infants and young children receive critical protection when their immune systems are most vulnerable to pathogens that could otherwise lead to severe diseases, such as pneumonia, meningitis, or even long-term disability as a complication.

Additions of new vaccinations

Often, these schedules (which in South Africa is call Extended Program for Immunisation - of EPI) undergoes expansion to include newer formulations, such as those for rotavirus and respiratory syncytial virus, reflecting a continuous evolution in preventive strategies aimed at mitigating the burden of diverse infectious diseases. Consequently, maintaining high immunization coverage is there for crucial, as global data indicates that millions of children especially in low and middle income countries (LMIC), currently remains unprotected or under-vaccinated, highlighting an urgent need for innovative implementation strategies. Most countries tend to address these coverage gaps by leveraging digital health records and localized outreach programs to systematically reach marginalized populations . Officials managing the South African healthcare system has recognized the utility of digital record keeping and surveillance for all vaccinations, and is actively working to put this in place.

This is the recommended schedule for vaccinations in South Africa, which has a nationally recommended childhood vaccination schedule provided FREE at public health clinics!

Here's what your child need to receive and when 👇

🔵 At Birth:

1. BCG (Tuberculosis protection)
2. OPV0 (Oral Polio Vaccine)

At 6 Weeks:

1. RV1 (Rotavirus)
2. DTaP-IPV-Hib-HepB (6-in-1 vaccine)
3. PCV (Pneumococcal)

At 10 Weeks:

1. DTaP-IPV-Hib-HepB
2. RV2

At 14 Weeks:

1. DTaP-IPV-Hib-HepB
2. PCV
3. RV3

🔴 6 Months:

1. Influenza (Flu vaccine)

At 9 Months:

1. Measles 1st dose
2. Influenza booster (Year 1)

🔵 12 Months:

1. PCV booster

At 18 Months:

1. DTaP-IPV-Hib booster
2. Measles 2nd dose

🔵 6 Years (Grade R):

1. Td (Tetanus & Diphtheria booster)
2. OPV

At 12 Years (Grade 7 Girls):

1. HPV (Human Papillomavirus) — 2 doses

💚 All vaccines on the EPI schedule are FREE at government clinics!

📍 Visit your nearest Community Health Centre or clinic today!

Beyond individual protection, these vaccination programs has shown to have significant long-term socioeconomic benefits by preventing childhood mortality and reducing the global burden of severe childhood diseases. Vaccination programs however, are not without its problems and limitations. Achieving hundred percent vaccine coverage as an outcome, necessitates overcoming persistent systemic hurdles, such as vaccine hesitancy (people who don’t believe in vaccines, and don’t get them) as well as logistical complexities within healthcare delivery networks (like maintaining the cold chain), vaccine availability and limited resources to purchase these vaccines on a regular basis. Vaccine hesitancy is often fuelled by the spread of misinformation, which significantly impedes the process of increasing accessing immunizations in underserved communities. Consequently, addressing these barriers requires comprehensive, targeted public education initiatives designed to foster trust in evidence-based medicine, coupled with sustained investment in robust cold-chain logistics and integrated digital health systems to ensure equitable, reliable access for every child. You might then wonder why even though 100% vaccination coverage is achieved, why then do some childhood diseases recur over time? The reason for this is that, some people don’t seroconvert into having the sensitizing the immune system to occur. Measles in particular, have approximately 10% of the people do not seroconvert their immune system when exposed to the Measles vaccination.

The implementation of life-course approaches, which establish vaccination contact points beyond infancy—such as during the second year of life, adolescence, and pregnancy—remains a core priority for sustained immunization coverage. To further bolster these efforts, healthcare providers should proactively review immunization histories during every clinical encounter to identify and address missed opportunities for vaccination. Such rigorous assessment protocols, supported by reliable vaccine supply chains and comprehensive digital records, are essential to ensure that children receive necessary doses in a timely manner, ultimately strengthening the resilience of community immunity.

Additionally, integrating state and local immunization information systems facilitates the use of reminder and recall notices, which have been proven to effectively increase compliance and close remaining coverage gaps. Moreover, implementing context-specific outreach strategies that address socioeconomic determinants, such as transportation barriers and parental time constraints, is vital to reaching zero-dose children and ensuring equitable service delivery . Systematic evaluation and implementation research must be integrated into these initiatives to build a robust evidence base for overcoming such programmatic challenges.

Moreover, minimizing vaccination dropouts requires a dual strategy of ensuring consistent vaccine availability to prevent stock-outs and training healthcare personnel to deliver culturally acceptable, high-quality services. Furthermore, adopting flexible delivery models, such as mobile clinics and school-based vaccination sites, serves to minimize geographic and financial barriers that frequently impede access to care. Additionally, engaging local civil society organizations can serve to bridge trust gaps and advocate for the inherent value of vaccination within marginalized communities.

Ultimately, fostering such community-driven partnerships alongside data-driven microplanning is essential to effectively identify and vaccinate ‘zero-dose’ populations in fragile or underserved settings. These efforts to close immunization gaps must also be synchronized with broader primary health care reforms to enhance system resiliency and secure sustainable financing. Such reforms are particularly critical given the persistent global surge in zero-dose children, which remains significantly higher than pre-pandemic levels. Addressing this challenge necessitates prioritizing interventions that align with the Zero Dose Guidelines, specifically targeting urban slums, remote rural areas, and conflict-affected zones where infrastructure is most vulnerable.

Leveraging frontline health workers to conduct community-based microplanning is essential to identify these clusters and facilitate the integration of immunization with other maternal and child health services. Recent research underscores that such integrated, transformative approaches are imperative for addressing multiple deprivations and effectively delivering routine immunization to previously missed populations. Specifically, harnessing the informal health sector holds significant potential to extend the reach of routine services to socioeconomically disadvantaged settings that current fixed-site facilities often fail to penetrate. Moreover, empirical evidence demonstrates that actively involving community leaders in the planning and execution of these outreach services significantly enhances local acceptance and long-term program sustainability.

Tasking trusted local entities with identifying and tracking these hard-to-reach populations, programs can overcome the lack of accurate population data and systemic guidance that often hinders monitoring efforts. Furthermore, documenting these implementation research projects provides a critical evidence base for identifying successful enablers and scalable strategies that effectively reduce persistent immunization inequities. Integrating geospatial technologies, such as hotspot analysis and equity mapping, further empowers practitioners to visualize coverage gaps and prioritize high-risk settlements with surgical precision. Moreover, the digitalization of these primary health care data systems offers a critical mechanism to inform adaptive decision-making, allowing for the precise targeting of resources to communities that have been historically underserved. Beyond these systemic improvements, developing context-specific strategies is essential, as zero-dose children are frequently located in diverse environments, ranging from dense urban slums to isolated rural outposts and conflict-affected regions. To overcome the limitations of rudimentary paper-based sketch maps that often omit vital geographic barriers and infrastructure constraints, programs must transition toward geo-referenced microplanning tools.

By incorporating Geographic Information Systems, health authorities can map population settlements with high precision, enabling the identification of hidden ‘zero-dose’ clusters that traditional monitoring systems frequently overlook. This transition not only enhances the accuracy of catchment area modeling but also allows for the dynamic adjustment of outreach services in response to changing demographic and environmental conditions.

Ultimately, such data-driven precision is indispensable for allocating scarce resources where they are most urgently needed, ensuring that programmatic interventions are both targeted and effective in reaching the most marginalized populations. Consequently, the systematic disaggregation of sub-national data serves as a vital diagnostic tool to uncover localized coverage inequities that aggregate national figures frequently obscure. By combining these spatial models with human-centered design, health systems can better address the interconnected root causes of under-immunization that lie beyond the immediate scope of traditional clinical services.

Implementing these comprehensive frameworks to achieve the maximum vaccine coverage, requires rigorous prioritization of local government areas, as seen in targeted initiatives that utilize bottom-up, community-engaged approaches to bridge critical service gaps. For instance, transitioning from manual documentation to digital monitoring solutions facilitates real-time feedback loops, which are essential for addressing the inconsistent data quality and naming discrepancies that often plague service delivery units.

References

Adamu, A. A., Jalo, R. I., Ndwandwe, D., & Wiysonge, C. S. (2024). Informal health sector and routine immunization: making the case for harnessing the potentials of patent medicine vendors for the big catch-up to reduce zero-dose children in sub-Saharan Africa. Frontiers in Public Health, 12. https://doi.org/10.3389/fpubh.2024.1353902

Adumashi, F. A., Obohwemu, K. O., Abayomi, G. O., Kenneth, I. O., Ekwuluo, C. E., & Ituah, F. (2026). Immunisation in the 21st Century: Foundations, Challenges, and Strategic Directions for Global Health. Advances in Social Sciences Research Journal, 13(2), 107–124. https://doi.org/10.14738/assrj.1302.19921

Afzal, S., & Siddiqui, M. (2024). Vaccination Across the Lifespan: A Public Health Imperative. Annals of King Edward Medical University, 30(3). https://doi.org/10.21649/akemu.v30i3.5843

Aheto, J. M. K., Olowe, I., Chan, H. M. T., Ekeh, A., Dieng, B., Fafunmi, B., Setayesh, H., Atuhaire, B., Crawford, J., Tatem, A. J., & Utazi, C. E. (2023). Geospatial Analyses of Recent Household Surveys to Assess Changes in the Distribution of Zero-Dose Children and Their Associated Factors before and during the COVID-19 Pandemic in Nigeria. Vaccines, 11(12), 1830–1830. https://doi.org/10.3390/vaccines11121830

Alegre, J. C. A., Sharma, S., Cleghorn, F., & Ávila, C. (2024). Strengthening primary health care in low- and middle-income countries: furthering structural changes in the post-pandemic era. Frontiers in Public Health, 11. https://doi.org/10.3389/fpubh.2023.1270510

Bakkabulindi, P., Ampeire, I., Ayebale, L., Mubiri, P., Feletto, M., & Muhumuza, S. (2023). Engagement of community health workers to improve immunization coverage through addressing inequities and enhancing data quality and use is a feasible and effective approach: An implementation study in Uganda. PLoS ONE, 18(10). https://doi.org/10.1371/journal.pone.0292053

Beaulieu, A., Ducharme, J., Thibeault, C., Akani, B. C., Ziegler, D., Hogan, D., Correa, G. C., Reynolds, H. W., & Johri, M. (2025). The Immunization Agenda 2030 Strategy to reach zero-dose children in low-income and middle-income countries: a scoping review. BMJ Global Health, 10(8). https://doi.org/10.1136/bmjgh-2024-018293

Chard, A. N., Gacic-Dobo, M., Diallo, M. S., Sodha, S. V., & Wallace, A. S. (2020). Routine Vaccination Coverage — Worldwide, 2019. MMWR Morbidity and Mortality Weekly Report, 69(45), 1706–1710. https://doi.org/10.15585/mmwr.mm6945a7

Decouttere, C., Boeck, K. D., & Vandaele, N. (2021). Advancing sustainable development goals through immunization: a literature review [Review of Advancing sustainable development goals through immunization: a literature review]. Globalization and Health, 17(1). BioMed Central. https://doi.org/10.1186/s12992-021-00745-w

Dias, E., Dias, A. P., & Baburaj, A. (2020). Common Vaccinations in Infants and Children- A Brief Review. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.3613403

Dias, E., monteiro, A. D., & Baburaj, A. (2019). Common Vaccinations in Infants and ChildrenA Brief Review. 3(2), 30–40.

Dobriyal, A. K., Dobriyal, S., & Kumar, K. (2024). Safeguarding the Future: The Critical Role of Child Vaccination in Cultivating aHealthy Generation. Himalayan Journal of Social Sciences and Humanities, 18(1). https://doi.org/10.51220/hjssh.v18i1.4

Dougherty, L., Abdulkarim, M., Mikailu, F., Tijani, U., Owolabi, K., Gilroy, K., Naiya, A., Abdullahi, A., Bodinga, H., Olayinka, F., & Moise, I. K. (2019). From paper maps to digital maps: enhancing routine immunisation microplanning in Northern Nigeria. BMJ Global Health, 4. https://doi.org/10.1136/bmjgh-2019-001606

Esposito, S., Abu-Raya, B., Bonanni, P., Cahn-Sellem, F., Flanagan, K. L., Martinón‐Torres, F., Mejías, A., Nadel, S., Sáfadi, M. A. P., & Simon, A. (2021). Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper [Review of Coadministration of Anti-Viral Monoclonal Antibodies With Routine Pediatric Vaccines and Implications for Nirsevimab Use: A White Paper]. Frontiers in Immunology, 12. Frontiers Media. https://doi.org/10.3389/fimmu.2021.708939

Farrenkopf, B. A., Zhou, X., Shet, A., Olayinka, F., Carr, K., Patenaude, B., Chido‐Amajuoyi, O. G., & Wonodi, C. (2023). Understanding household-level risk factors for zero dose immunization in 82 low- and middle-income countries. PLoS ONE, 18(12). https://doi.org/10.1371/journal.pone.0287459

Feldstein, L. R., Mariat, S., Gacic-Dobo, M., Diallo, M. S., Conklin, L., & Wallace, A. S. (2017). Global Routine Vaccination Coverage, 2016. MMWR Morbidity and Mortality Weekly Report, 66(45), 1252–1255. https://doi.org/10.15585/mmwr.mm6645a3

Grant, G. B., Reef, S. E., Patel, M., Knapp, J. K., & Dabbagh, A. (2017). Progress in Rubella and Congenital Rubella Syndrome Control and Elimination — Worldwide, 2000–2016. MMWR Morbidity and Mortality Weekly Report, 66(45), 1256–1260. https://doi.org/10.15585/mmwr.mm6645a4

Hill, H. A., Chen, M., Elam–Evans, L. D., Yankey, D., & Singleton, J. A. (2023). Vaccination Coverage by Age 24 Months Among Children Born During 2018–2019 — National Immunization Survey–Child, United States, 2019–2021. MMWR Morbidity and Mortality Weekly Report, 72(2), 33–38. https://doi.org/10.15585/mmwr.mm7202a3

Hill, H. A., Yankey, D., Elam–Evans, L. D., Chen, M., & Singleton, J. A. (2023). Vaccination Coverage by Age 24 Months Among Children Born in 2019 and 2020 — National Immunization Survey-Child, United States, 2020–2022. MMWR Morbidity and Mortality Weekly Report, 72(44), 1190–1196. https://doi.org/10.15585/mmwr.mm7244a3

Hill, H. A., Yankey, D., Elam–Evans, L. D., Singleton, J. A., & Sterrett, N. (2021). Vaccination Coverage by Age 24 Months Among Children Born in 2017 and 2018 — National Immunization Survey-Child, United States, 2018–2020. MMWR Morbidity and Mortality Weekly Report, 70(41), 1435–1440. https://doi.org/10.15585/mmwr.mm7041a1

Hogan, D., & Gupta, A. (2023). Why Reaching Zero-Dose Children Holds the Key to Achieving the Sustainable Development Goals. Vaccines, 11(4), 781–781. https://doi.org/10.3390/vaccines11040781

Khan, S., Gupta, G. K., Agrawal, D., Zaidi, S. H. N., Batra, J., Syed, S., Sharma, L., Khambira, M., Haile, D. A., Sethy, G., & Singh, S. K. (2024a). The Big Catch-up: Addressing Zero-Dose Children as a Surrogate of Vaccination Disruptions During Public Health Emergencies. European Scientific Journal ESJ, 33. https://doi.org/10.19044/esipreprint.9.2024.p286

Khan, S., Gupta, G. K., Agrawal, D., Zaidi, S. H. N., Batra, J., Syed, S., Sharma, L., Khambira, M., Haile, D. A., Sethy, G., & Singh, S. K. (2024b). The Big Catch-up: Addressing Zero-Dose Children as a Surrogate of Vaccination Disruptions During Public Health Emergencies: A review of literature. European Scientific Journal ESJ, 20(36), 19–19. https://doi.org/10.19044/esj.2024.v20n36p19

Majeed, Z. A., Ahmad, N., Mere, O., Farrukh, S., Mohsni, E., Derow, M., Cuen, A., Mohamed, M. G., Patni, M. A., Gunaid, M. A., Khader, Y., Nsour, M. A., & Bashier, H. (2025). Innovative and sustainable solutions for reducing ‘zero-dose’ vaccination: How can the region respond? Frontiers in Public Health, 13. https://doi.org/10.3389/fpubh.2025.1652977

Malik, M. Z., Mian, N. uddin, Memon, Z., Mirza, M. W., Rana, U. F., Alvi, M. A., Ahmed, W., Ummad, A., Ali, A., Naveed, U., Malik, K. S., Chaudhary, M. S., Waheed, M., & Sattar, A. (2026). Digital monitoring and action planning to reach zero-dose and under-immunised children: Leveraging data for targeted immunisation responses. medRxiv.https://doi.org/10.64898/2026.03.03.26346932

Muhoza, P., Danovaro‐Holliday, M. C., Diallo, M. S., Murphy, P., Sodha, S. V., Requejo, J., & Wallace, A. S. (2021). Routine Vaccination Coverage — Worldwide, 2020. MMWR Morbidity and Mortality Weekly Report, 70(43), 1495–1500. https://doi.org/10.15585/mmwr.mm7043a1

Neunez, M., Goldman, M., Goldman, S., & Lambert, P. (2019). Vaccines, Shots That Protect You. Frontiers for Young Minds, 7. https://doi.org/10.3389/frym.2019.00031

Oyugi, B., Källander, K., & Shahabuddin, A. (2025). Strengthening Primary Health Care Through Implementation Research: Strategies for Reaching Zero-Dose Children in Low- and Middle-Income Countries’ Immunization Programs. Vaccines, 13(10), 1040–1040. https://doi.org/10.3390/vaccines13101040

Peck, M. E., Gacic-Dobo, M., Diallo, M. S., Nedelec, Y., Sodha, S. S., & Wallace, A. S. (2019). Global Routine Vaccination Coverage, 2018. MMWR Morbidity and Mortality Weekly Report, 68(42), 937–942. https://doi.org/10.15585/mmwr.mm6842a1

Piot, P., Larson, H. J., O’Brien, K. L., Nkengasong, J. N., Ng, E. S. W., Sow, S. O., & Kampmann, B. (2019). Immunization: vital progress, unfinished agenda [Review of Immunization: vital progress, unfinished agenda]. Nature, 575(7781), 119–129. Nature Portfolio. https://doi.org/10.1038/s41586-019-1656-7

Pollard, A. J., & Bijker, E. M. (2020). A guide to vaccinology: from basic principles to new developments [Review of A guide to vaccinology: from basic principles to new developments]. Nature Reviews. Immunology, 21(2), 83–100. Nature Portfolio. https://doi.org/10.1038/s41577-020-00479-7

Rachlin, A., Danovaro‐Holliday, M. C., Murphy, P., Sodha, S. V., & Wallace, A. S. (2022). Routine Vaccination Coverage — Worldwide, 2021. MMWR Morbidity and Mortality Weekly Report, 71(44), 1396–1400. https://doi.org/10.15585/mmwr.mm7144a2

Sabahelzain, M. M., Almaleeh, A., Abdelmagid, N., Abdalla, O., Nor, B., Mounier‐Jack, S., & Singh, N. (2024). Vaccination strategies to identify and reach zero-dose and under-immunized children in crisis-affected states in Sudan: a qualitative study. Conflict and Health, 18(1). https://doi.org/10.1186/s13031-024-00639-9

Sadowska, I., Kułak, K., Palacz, K. A., Pliszka, M., Janik, I., Gadżała, K., Chamera-Cyrek, K., Koman, A. M., Kuśmierska, M., & Przygodzka, S. (2024). The Increasing Occurrence of Infectious Diseases in Childhood: Is It Linked with Declining Vaccination Rates Across Society? Journal of Education Health and Sport, 74, 52556–52556. https://doi.org/10.12775/jehs.2024.74.52556

Shen, A. K., Fields, R., & McQuestion, M. (2014). The future of routine immunization in the developing world: challenges and opportunities. Global Health Science and Practice, 2(4), 381–394. https://doi.org/10.9745/ghsp-d-14-00137

Siddiqi, D. A., Memon, M., Iftikhar, S., Siddique, M., Dharma, V. K., Ahmad, A. M., Safdar, N., Shah, M. T., Setayesh, H., Sodhar, I. A., Malik, F. R., & Chandir, S. (2025). Estimating prevalence and identifying predictors of zero-dose pentavalent and never-immunized children under two years of age in Kashmore and Sujawal Districts of Sindh, Pakistan: An analysis of household survey data. PLoS ONE, 20(8). https://doi.org/10.1371/journal.pone.0330281

Singh, A. K. (2026). Strengthening urban immunization through GIS-supported microplanning practices. International Journal of Applied Research, 12(2), 310–319. https://doi.org/10.22271/allresearch.2026.v12.i2d.13398

Skolnik, A., Bhatti, A., Larson, A., & Mitrovich, R. (2021). Silent Consequences of COVID-19: Why It’s Critical to Recover Routine Vaccination Rates Through Equitable Vaccine Policies and Practices. The Annals of Family Medicine, 19(6), 527–531. https://doi.org/10.1370/afm.2730

Tiwari, Ms. N., Kumar, Prof. R. S., David, Ms. S., Panthri, Ms. K., Pal, Ms. M., Kumar, Z. N., & Varghese, Prof. Dr. J. (2023). Enhancing Child Health: The Crucial Role of Pediatric Nurses in Childhood Immunization – A Comprehensive Review [Review of Enhancing Child Health: The Crucial Role of Pediatric Nurses in Childhood Immunization – A Comprehensive Review]. Journal of Chemical Health Risks. Azad University Cross Team. https://doi.org/10.53555/jchr.v13.i4s.1631

Zhou, F., Jatlaoui, T. C., Leidner, A. J., Carter, R. J., Dong, X., Santoli, J. M., Stokley, S., Daskalakis, D., & Peacock, G. (2024). Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program — United States, 1994–2023. MMWR Morbidity and Mortality Weekly Report, 73(31), 682–685. https://doi.org/10.15585/mmwr.mm7331a2

Андреевна, Н. В. (2026a). ANALYSIS OF REASONS FOR DISRUPTION OF THE VACCINATION SCHEDULES IN CHILDREN UNDER 3 YEARS OLD. In Open MIND.

Андреевна, Н. В. (2026b). АНАЛИЗ ПРИЧИН НАРУШЕНИЯ ГРАФИКА ВАКЦИНАЦИИ ДЕТЕЙ В ВОЗРАСТЕ ДО 3 ЛЕТ. Cyberleninka.Ru. https://doi.org/10.24412/cl-34438-2026-179-186-191